Elevance Health EBITDA 2010-2024 | ELV

Elevance Health annual and quarterly EBITDA history from 2010 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • Elevance Health EBITDA for the quarter ending September 30, 2024 was $2.002B, a 14.41% decline year-over-year.
  • Elevance Health EBITDA for the twelve months ending September 30, 2024 was $10.822B, a 2.55% increase year-over-year.
  • Elevance Health 2023 annual EBITDA was $10.49B, a 3.59% increase from 2022.
  • Elevance Health 2022 annual EBITDA was $10.126B, a 0.1% increase from 2021.
  • Elevance Health 2021 annual EBITDA was $10.116B, a 23.19% increase from 2020.
Elevance Health Annual EBITDA
(Millions of US $)
2023 $10,490
2022 $10,126
2021 $10,116
2020 $8,212
2019 $7,866
2018 $6,964
2017 $5,876
2016 $6,190
2015 $6,183
2014 $5,901
2013 $5,497
2012 $5,111
2011 $5,025
2010 $5,374
2009 $8,404
Elevance Health Quarterly EBITDA
(Millions of US $)
2024-09-30 $2,002
2024-06-30 $3,601
2024-03-31 $3,535
2023-12-31 $1,684
2023-09-30 $2,339
2023-06-30 $3,135
2023-03-31 $3,332
2022-12-31 $1,747
2022-09-30 $2,791
2022-06-30 $2,723
2022-03-31 $2,865
2021-12-31 $2,046
2021-09-30 $2,548
2021-06-30 $2,872
2021-03-31 $2,650
2020-12-31 $1,094
2020-09-30 $925
2020-06-30 $3,639
2020-03-31 $2,554
2019-12-31 $1,537
2019-09-30 $1,975
2019-06-30 $1,934
2019-03-31 $2,420
2018-12-31 $1,013
2018-09-30 $1,717
2018-06-30 $1,981
2018-03-31 $2,253
2017-12-31 $798
2017-09-30 $1,493
2017-06-30 $1,614
2017-03-31 $1,971
2016-12-31 $1,068
2016-09-30 $1,538
2016-06-30 $1,860
2016-03-31 $1,724
2015-12-31 $778
2015-09-30 $1,263
2015-06-30 $2,201
2015-03-31 $1,941
2014-12-31 $1,249
2014-09-30 $1,525
2014-06-30 $1,630
2014-03-31 $1,496
2013-12-31 $853
2013-09-30 $1,408
2013-06-30 $1,588
2013-03-31 $1,648
2012-12-31 $819
2012-09-30 $1,346
2012-06-30 $1,348
2012-03-31 $1,598
2011-12-31 $771
2011-09-30 $1,305
2011-06-30 $1,266
2011-03-31 $1,684
2010-12-31 $1,023
2010-09-30 $1,399
2010-06-30 $1,377
2010-03-31 $1,574
2009-12-31 $4,580
2009-09-30 $1,367
2009-06-30 $1,311
2009-03-31 $1,145
Sector Industry Market Cap Revenue
Medical Medical Services $96.890B $171.340B
Elevance Health Inc. operates as a health benefits company. It supports consumers, families and communities across the entire care journey connecting to the care, support and resources to lead healthier lives. Elevance Health Inc., formerly known as Anthem Inc., is based in Indianapolis, Indiana.
Stock Name Country Market Cap PE Ratio
Cencora (COR) United States $46.107B 17.62
DiDi Global (DIDIY) China $23.233B 0.00
ICON (ICLR) Ireland $18.679B 16.64
Revvity (RVTY) United States $15.535B 26.63
Avantor (AVTR) United States $15.498B 23.24
Natera (NTRA) United States $15.385B 0.00
Viatris (VTRS) United States $13.858B 4.22
BioMerieux (BMXMF) France $13.601B 0.00
Solventum (SOLV) United States $12.636B 0.00
CochLear (CHEOY) Australia $12.565B 0.00
Medpace Holdings (MEDP) United States $10.202B 28.74
Charles River Laboratories (CRL) United States $9.742B 18.41
Sonic Healthcare (SKHHY) Australia $8.273B 0.00
HealthEquity (HQY) United States $7.792B 42.29
Doximity (DOCS) United States $7.787B 49.34
Bausch + Lomb (BLCO) Canada $6.975B 32.47
Life Times (LTH) United States $4.762B 31.52
PACS (PACS) United States $4.502B 0.00
Sotera Health (SHC) United States $4.367B 23.36
Organon (OGN) United States $4.239B 4.28
Surgery Partners (SGRY) United States $3.778B 41.86
BrightSpring Health Services (BTSG) United States $3.070B 65.30
Ardent Health Partners (ARDT) United States $2.577B 0.00
Alignment Healthcare (ALHC) United States $2.546B 0.00
Concentras Parent (CON) United States $2.480B 0.00
Premier (PINC) United States $2.271B 11.34
GoodRx Holdings (GDRX) United States $2.254B 84.86
GeneDx Holdings (WGS) United States $2.057B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
Teladoc Health (TDOC) United States $1.575B 0.00
AMN Healthcare Services Inc (AMN) United States $1.507B 7.57
Progyny (PGNY) United States $1.425B 25.06
Establishment Labs Holdings (ESTA) $1.338B 0.00
Pediatrix Medical (MD) United States $1.319B 12.91
CareDx (CDNA) United States $1.228B 0.00
Agilon Health (AGL) United States $1.123B 0.00
Embecta (EMBC) United States $0.864B 5.76
InnovAge Holding (INNV) United States $0.822B 0.00
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
SBC Medicals (SBC) United States $0.722B 0.00
Auna S.A (AUNA) Luxembourg $0.488B 0.00
Sonida Senior Living (SNDA) United States $0.483B 0.00
Enhabit (EHAB) United States $0.382B 33.04
DocGo (DCGO) United States $0.355B 13.35
COMPASS Pathways (CMPS) United Kingdom $0.309B 0.00
Sera Prognostics (SERA) United States $0.255B 0.00
ModivCare (MODV) United States $0.232B 7.37
Beauty Health (SKIN) United States $0.211B 0.00
Biodesix (BDSX) United States $0.195B 0.00
LifeMD (LFMD) United States $0.192B 0.00
Ascend Wellness Holdings (AAWH) United States $0.178B 0.00
MultiPlan (MPLN) United States $0.136B 0.00
Nutex Health (NUTX) United States $0.127B 0.00
So-Young (SY) China $0.092B 22.35
Harvard Apparatus Regenerative Technology (HRGN) United States $0.059B 0.00
Singular Genomics Systems (OMIC) United States $0.057B 0.00
OncoCyte (OCX) United States $0.049B 0.00
NeueHealth (NEUE) United States $0.041B 1.63
Co-Diagnostics (CODX) United States $0.039B 0.00
IceCure Medical (ICCM) Israel $0.036B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.027B 0.00
Pheton Holdings (PTHL) China $0.027B 0.00
Oncology Institute (TOI) United States $0.021B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
XWELL (XWEL) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.007B 0.00
BioNexus Gene Lab (BGLC) $0.007B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00